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Abstract
Castleman's disease is a rare lymphoproliferative disorder. Most cases occur in the mediastinum
and the pancreatic localization is uncommon; currently there are only nine reported cases in the
literature about peripancreatic localization. We report a case of a 62 years old man with a
Castleman's disease mimicking a pancreatic neoplasm.
Introduction
Castleman's disease (CD) or angiofollicular lymph node
hyperplasia is a rare lymphoproliferative disorder of
unknown aetiology first described in 1954 by B. Castle-
man and V.W. Towne as an asymptomatic benign hyper-
plastic lymph node resembling a thymoma[1,2]. Most of
the lesions are located in the thorax (70%), but extratho-
racic involvement (neck, axilla, mesentery and retroperi-
toneum) have also been reported [3-6].
When CD is localized in retroperitoneum it has no dis-
tinctive clinical or radiological features and it can be con-
fused with other retroperitoneal tumours or, as in our
description, with vascular anomaly. We report the case of
a CD Tumour, mimicking a pancreatic mass and initially
diagnosed as an aneurysm of the left gastric artery [7-10].
Case report
A 62 year old man with nephrolithiasis history underwent
an ultrasonography scan (US) with occasional report of
cystic mass of 38 × 28 mm localized in the pancreatic
body, close to the tail (April 2nd, 2008, as shown in figure
1).
The radiologist recommended a Magnetic Resonance
Imaging (MRI) and a fine needle agobiopsy to character-
ize the lesion interpreted as a pancreatic cystoadenoma or
a dysontogenetic cyst. The MRI (performed on April 22nd
- figure 2) described a mass of 38 mm localized in front of
the pancreas body and behind the lesser gastric curvature,
maybe a supernumerary spleen, this hypothesis to be con-
firmed with a Computed tomography (CT) scan.
The CT scan was performed on May the 7th: it revealed a
fluid, roundish mass less than 40 mm of maximum diam-
eter between lesser curvature and pancreatic body with
contrast enhancement as arterial blood, perhaps aneu-
rysm of left gastric artery.
A Doppler Sonography (May 21st, see figure 3) showed a
thrombosis of a splenic artery aneurysm.
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The patient underwent on June 18th to a transfemoral
arteriography that demonstrated an aneurysm of the left
gastric artery of 40 mm not confirmed in a selective arteri-
ography performed on June 24th; showed in figure 4.
Another doppler sonography on the same day gave evi-
dence of a peripancreatic iso-anechogenic mass.
A MRI (July 7th) displayed a sovramesocolic mass
between lesser curvature and gastric body: gastrointestinal
stromal tumor (GIST) or hemangiopericytoma.
On September 12th a contrast-enhanced sonography tes-
tified an ipo-anechogenic mass of 36 mm in the pancre-
atic body as a not active neuroendocrinal neoplasm; on
the same date an endo-ultrasonography deposed for an
extragastric mass, with no certain cleavage with pancreas
(the brown words do not make sense to me) of 36 mm of
maximum diameter and satellite lymphadenopathy.
The patient was admitted to our unit on October 13th
after all the exams and procedures described above and
with no certain diagnosis. His past medical history
showed type II diabetes mellitus, hypertension, hyperuri-
cemia and hypertriglyceridaemia. Laboratory tests were
Ultrasonography scan with occasional report of cystic mass  of 38 × 28 mm localized in the pancreatic body Figure 1
Ultrasonography scan with occasional report of 
cystic mass of 38 × 28 mm localized in the pancreatic 
body.
MRI describing a mass of 38 mm localized in front of the pan- creas body Figure 2
MRI describing a mass of 38 mm localized in front of 
the pancreas body.
Doppler sonography showing a thrombosis of a splenic  artery aneurysm Figure 3
Doppler sonography showing a thrombosis of a 
splenic artery aneurysm.
Transfemoral arteriography demonstrating an aneurysm of  the left gastric artery of 40 mm Figure 4
Transfemoral arteriography demonstrating an aneu-
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normal except for mild hyperglicemia (117 g/dL) and a
slight γ-GT increase (104 IU/L). There was no serological
indication of active HIV, B and C hepatitis, past Epstein
Barr virus and Cytomegalovirus infections and tumor
markers as CEA and CA19.9 were normal. A colonoscopy
was performed that showed a diverticulosis. The patient
underwent surgical operation for suspected pancreatic
neoplasm. At laparotomy the pancreas appeared normal
as well as the liver and other organs. (It was found) A
voluminous well vascularized 4 cm mass was found along
the lesser gastric curvature, not contacting the gastric body
or the pancreas. The laparotomy was restricted to dissect
the mass. The postoperative course was uneventful and
the patient was discharged on 5th day. Frozen section of
the mass showed an atypical lymphoproliferative process
with no clonal rearrangement of IgH gene at molecular
studies; the final pathological report described an
angiofollicular lymphoid hyperplasia compatible with
mixed variety, hyaline-vascular plasma cell type of CD
made of preserved lymphoid tissue with follicles at vari-
ous degree of maturation and diffuse hyaline involution
and intervening sheets of plasma cells and capillary.
He is alive and free of recurrence at 4 months follow-up.
Discussion
Castleman's Disease usually presents in young adults with
a median age of approximately 35 years, equally distrib-
uted between males and females; The cause of this disor-
der is not known and it may be caused by a faulty
immunoregulation which results in the excessive prolifer-
ation of B lymphocytes and plasmacells in lymphoid
organs; human Herpes virus-8 and Epstein Barr virus may
play a role especially in immunocompromised hosts.
According to Keller, McCarty, Gaba et al. 6 there are two
types of CD, either a localized type (with a typical benign
course), or a plurifocal, also called "multicentric", type
which has usually malignant course [4,6,7]. In these two
clinical entities have been described two distinct histolog-
ical types and a mixed variant: the hyaline-vascular type,
most frequent, and the plasmocytic type (10% of total
cases). The former is clinically almost asymptomatic while
the plasmocytic type is sometimes associated with sys-
temic manifestation such as anaemia, weight loss, night
sweats, fever and polyclonal hypergammaglobulinemia; it
is also frequently associated with Acquired Immunodefi-
ciency Syndrome, Kaposi sarcoma and POEMS syndrome
(polineuropathy, organomegaly, endocrinopathy, M pro-
tein and skin changes) [7,8]. CD has no specific radiolog-
ical features and it is almost indistinguishable from other
disease and the features of neoplastic and non-neoplastic
lesions and those with a malignant potential is poor. In a
retrospective study by Bowne surgical excision has been
associated with the best chance of cure for localised dis-
ease [10]; for multicentric disease the treatment has not
been established due to its variable clinical course
(chronic evolution with remission and exacerbation or
rapidly progressive and fatal course) [7,9]. Corticoster-
oids, antimitotics, radiotheraphy and excision are, at the
present, the therapeutic approaches. Surgery is both diag-
nostic and therapeutic and laparoscopic approach may be
the gold standard for diagnosis and treatment [10]. Radi-
ation therapy has been used with varied success in
patients who are poor surgical candidates or in those with
unresectable lesions.
A better understanding of the pathogenesis, natural his-
tory, and ultimately diagnosis of this disorder may lead to
improvement over the current modalities available for
treatment.
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